BHL
Black Horse Mining
Black Horse Mining Limited is focused on reactivating the historical Mt Egerton gold mines near Ballarat in Victoria, Australia. The company holds a 51% interest and is earning up to 80% by spending $4 million over five years on exploration and development, targeting a high-grade gold operation.
Shorted
About
website
industry
Key Metrics
More Materials Stocks
Other shorted stocks in this sector
Short Position Trends
Track bearish sentiment and short interest over time
Historical Price Data
View stock price movements, volume, and trading patterns
Industry & Focus
Company Overview
AI-generated company summary
Black Horse Mining Limited is focused on reactivating the historical Mt Egerton gold mines near Ballarat in Victoria, Australia. The company holds a 51% interest and is earning up to 80% by spending $4 million over five years on exploration and development, targeting a high-grade gold operation.
Company History
Black Horse Mining Limited is dedicated to reactivating a million-ounce goldfield in Victoria’s premier gold belt. Mt Egerton is one of only eight gold mines in Victoria to produce over 1 million ounces of gold from primary rock (not alluvial). Operations ceased in 1906 due to water ingress and failure of pumping equipment. The Company plans to undertake drilling and other investigatory work to define resources and reserves.
Competitive Advantages
High-grade gold operation potential: Mt Egerton is one of only eight gold mines in Victoria to produce over 1 million ounces of gold from primary rock (not alluvial). Prolific gold producing zone: Mt Egerton lies within the Bendigo-Ballarat zone; one of the most prolific gold producing zones in the world with over 80 million ounces produced to date.
Risk Factors
- •Exploration risk
- •Funding risk
- •Operational risk
Key People
Leadership team at Black Horse Mining
David Frances
CEO
Managing Director & CEO
Peter Wall
Chair
Non-Executive Chairman and Partner at Steinepreis Paganin.
Charles McHugh
Director
Non-Executive Director
Mr. David John Frances B.Sc., BSc (Hons)
MD, CEO & Director
Mr. Ian Hobson
Company Secretary